Observes a balloon catheter procedure to treat irregular heartbeat in atrial fibrillation
Follows adults with atrial fibrillation who receive a radiofrequency balloon catheter treatment.
Plain-language title generated from the registry record
Registry title: Multicenter Registry of Atrial Fibrillation Ablation With Radiofrequency Balloon Catheter
Key facts
- Where
- Brussels, BelgiumSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with symptomatic atrial fibrillation who are having catheter ablation with the Heliostar radiofrequency balloon catheter.
- Age
- 18 to 85 years
- Sex
- All sexes can join
- Disease stage
- Paroxysmal or persistent atrial fibrillation with symptoms and an indication for catheter ablation
Main reasons for not taking part
- Under 18 years old
- Pregnancy
- Any contraindication to catheter ablation
Read by machine on 9 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
Source: NCT06333327, who can take part
Where in Belgium
- UZ Brussel Heart Rhythm Management CenterBrussels, BelgiumContact: Carlo de Asmundis, MD, PhDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Universitair Ziekenhuis Brussel
- Trial code
- NCT06333327
- Record updated
- 27 March 2024
- Original description
All consecutive patients with paroxysmal or persistent atrial fibrillation undergoing pulmonary vein isolation with the radiofrequency balloon catheter (RFB) "Heliostar" (Biosense Webster) will be included in a multicenter observational registry. The aim of the study is to assess the safety and arrhythmic outcome of atrial fibrillation ablation with the RFB in a real-world setting.Read full original descriptionShow less
Multielectrode Radiofrequency Balloon for Atrial Fibrillation Catheter Ablation: A Multicenter Real-World Experience
All consecutive patients with paroxysmal or persistent atrial fibrillation undergoing pulmonary vein isolation with the radiofrequency balloon catheter (RFB) "Heliostar" (Biosense Webster) will be included in a multicenter observational registry. The aim of the study is to assess the safety and arrhythmic outcome of atrial fibrillation ablation with the RFB in a real-world setting.
Inclusion: symptomatic atrial fibrillation with indication to catheter ablation.
Exclusion: age <18 years old; pregnancy; any contraindications to catheter ablation.